Year: 2022

news_6

Organon Enters into Global License Agreement to Commercialize Henlius’ Investigational Perjeta® (Pertuzumab) and Prolia®/Xgeva® (Denosumab) Biosimilar Candidates

Collaboration expands and underscores commitment to biosimilars portfolio and focus on women’s health with biosimilar candidates for osteoporosis and breast...

news_6

Asia Cervical Cancer Test (Screening) Market Report 2021-2027: Size, Forecasts, Industry Trends, Share, Growth, Impact of COVID-19 – ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Asia Cervical Cancer Test (Screening) Market, Size, Forecast 2022-2027, Industry Trends, Share, Growth, Impact of COVID-19" report has...